Dyadic International (DYAI) News Today → How to Make 100X on the AI Boom (From InvestorPlace) (Ad) Free DYAI Stock Alerts $1.49 -0.04 (-2.61%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 4:36 PM | msn.comDyadic International GAAP EPS of -$0.07, revenue of $0.34MMay 14 at 4:00 PM | globenewswire.comDyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company ProgressMay 14 at 6:15 AM | investing.comDyadic (DYAI) Earnings Dates & ReportsMay 12 at 1:56 AM | americanbankingnews.comDyadic International (DYAI) Set to Announce Earnings on TuesdayMay 8, 2024 | globenewswire.comDyadic to Attend Industry and Investor Events in MayMay 7, 2024 | investing.comDyadic International Inc (DYAI)May 4, 2024 | fool.comDyadic International (NASDAQ: DYAI)April 30, 2024 | globenewswire.comDyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024April 24, 2024 | msn.comDyadic International files to sell 3.35M shares for holdersApril 1, 2024 | msn.comDYAI: Capital Raise to Accelerate Near Term Revenue GrowthApril 1, 2024 | insidermonkey.comDyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call TranscriptMarch 30, 2024 | seekingalpha.comDyadic International, Inc. (DYAI) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | finance.yahoo.comQ4 2023 Dyadic International Inc Earnings CallMarch 28, 2024 | benzinga.comRecap: Dyadic International Q4 EarningsMarch 28, 2024 | globenewswire.comDyadic Reports 2023 Full Year Results and Recent Company ProgressMarch 28, 2024 | globenewswire.comDyadic Announces Change in Board and Management Leadership RolesMarch 27, 2024 | globenewswire.comDyadic to Attend Industry Events in AprilMarch 26, 2024 | globenewswire.comDyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature CommunicationsMarch 21, 2024 | globenewswire.comDyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, CaliforniaMarch 14, 2024 | globenewswire.comDyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024March 11, 2024 | finance.yahoo.comDyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and CommercializationMarch 11, 2024 | globenewswire.comCORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and CommercializationMarch 11, 2024 | globenewswire.comDyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and CommercializationMarch 1, 2024 | globenewswire.comDyadic to Attend Industry Events in MarchFebruary 29, 2024 | ca.finance.yahoo.comDYAI Aug 2024 2.500 callFebruary 29, 2024 | ca.finance.yahoo.comDYAI Apr 2024 2.500 callFebruary 28, 2024 | msn.comDyadic announces strategic partnership agreement to develop rabies vaccinesFebruary 28, 2024 | globenewswire.comDyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production PlatformFebruary 23, 2024 | globenewswire.comDyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease SolutionsFebruary 21, 2024 | finance.yahoo.comDyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease SolutionsFebruary 21, 2024 | finance.yahoo.comDyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease SolutionsFebruary 21, 2024 | globenewswire.comDyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease SolutionsFebruary 20, 2024 | finance.yahoo.comDYAI: Catching Up With DyadicFebruary 6, 2024 | msn.comDyadic signs R&D agreement with global biopharmaceutical companyFebruary 1, 2024 | finance.yahoo.comDyadic to Attend BIO CEO & Investor Conference and European Industry EventsJanuary 22, 2024 | finance.yahoo.comDyadic International, Inc Invites You to Join Us at The Microcap ConferenceJanuary 3, 2024 | morningstar.comDyadic International Inc DYAINovember 30, 2023 | finance.yahoo.comDyadic Attends Investor Events in DecemberNovember 29, 2023 | finance.yahoo.comDyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine CandidateNovember 22, 2023 | finance.yahoo.comShareholders in Dyadic International (NASDAQ:DYAI) are in the red if they invested three years agoNovember 20, 2023 | markets.businessinsider.comDyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in AfricaNovember 20, 2023 | finance.yahoo.comDyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in AfricaNovember 13, 2023 | markets.businessinsider.comDyadic International’s Promising Outlook: COVID-19 Vaccine Progress, Strategic Collaborations, and Financial StabilityNovember 9, 2023 | finance.yahoo.comDYAI: Third Quarter UpdateNovember 9, 2023 | finance.yahoo.comDyadic International, Inc. (NASDAQ:DYAI) Q3 2023 Earnings Call TranscriptNovember 8, 2023 | benzinga.comRecap: Dyadic International Q3 EarningsNovember 8, 2023 | finance.yahoo.comDyadic Announces Third Quarter 2023 Financial Results and Highlights Recent Company ProgressNovember 8, 2023 | finance.yahoo.comDyadic International Inc (DYAI) Reports Decrease in Q3 Revenue and Net Loss Improvement ...October 30, 2023 | finance.yahoo.comDyadic to Present at Industry Events in NovemberOctober 25, 2023 | finance.yahoo.comDyadic to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023 Get Dyadic International News Delivered to You Automatically Sign up to receive the latest news and ratings for DYAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden FINISHED On June 13th? (Ad)Thanks to Biden’s disgraceful leadership we now have sky-high inflation… unchecked immigration… rampant crime… and a “woke mob” hell bent on destroying the America you and I know and love. Biden’s days are numbered. Click here now to see his shocking evidence. DYAI Media Mentions By Week DYAI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DYAI News Sentiment▼0.470.57▲Average Medical News Sentiment DYAI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DYAI Articles This Week▼41▲DYAI Articles Average Week Get Dyadic International News Delivered to You Automatically Sign up to receive the latest news and ratings for DYAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OKYO Pharma News Quince Therapeutics News Cyclo Therapeutics News IN8bio News SAB Biotherapeutics News Achilles Therapeutics News Protara Therapeutics News MiNK Therapeutics News Surrozen News Pluri News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DYAI) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAmerica’s worst nightmare?Porter & CompanyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyadic International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
